Quantitative bone marrow magnetic resonance imaging in children with lymphoblastic leukaemia

Cover Page

Cite item

Full Text

Abstract

The aim of the study was to evaluate fat fraction (FF) changes in patients diagnosed with acute lymphoblastic leukaemia (ALL) in comparison with children without haematological disorders. All the patients or their legal representatives gave their informed consent to magnetic resonance imaging (MRI). The study was approved by the Independent Ethics Committee and the Scientific Council of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology and was conducted in line with the Ethical Principles of the World Health Organization (the Declaration of Helsinki) for Medical Research Involving Human Subjects. The study included 33 healthy volunteers aged 13.4 ± 2.8 years (the control group) and 34 patients with acute phase ALL whose mean age was 12.2 ± 3.6 years (the group of interest). Imaging of the pelvic bones and lumbar vertebrae was performed on a Philips Achieva 3T scanner using the mDixon-quant sequence, with a subsequent construction of FF maps. The Mann–Whitney U-test was used to compare the FF data of the cases with each other and with the controls. Four regions of interest were selected, 100 mm2 each: in the bodies of the right and the left iliac bones as well as in the bodies of the L4 and L5 vertebras. For each group of subjects and each region of interest, mean FF was calculated. In the group of the patients with acute phase ALL, FF was the lowest: 3.53 ± 2.75% and 3,72 ± 3.09% in the bodies of the left and right iliac bones respectively, and 2.62 ± 1.86% and 2.47 ± 2.17% in the L4 and L5 vertebras respectively. In the control group, FF in the respective regions of interest was 51.3 ± 9.5%; 49.9 ± 11.0%; 31.3 ± 8.73% and 32.4 ± 10.3%. It is obvious that bone marrow FF in the patients with ALL differs significantly from the control group. Quantitative MRI can become a new method for the assessment of changes in the bone marrow of children with leukaemias.

About the authors

G. V. Tereshchenko

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of the Ministry of Healthcare of the Russian Federation

ORCID iD: 0000-0001-7317-7104

Moscow

Russian Federation

N. A. Kriventsova

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of the Ministry of Healthcare of the Russian Federation

Author for correspondence.
Email: nataliya.krivencova@fccho-moscow.ru
ORCID iD: 0000-0003-4164-004X

Natalia A. Kriventsova - a radiologist and a research technician at the Department of Diagnostic Radiology.

1 Samory Mashela St., Moscow 117997

Russian Federation

D. A. Kupriyanov

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of the Ministry of Healthcare of the Russian Federation

ORCID iD: 0000-0002-5662-896X

Moscow

Russian Federation

M. I. Abu Jabal

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of the Ministry of Healthcare of the Russian Federation

Moscow

Russian Federation

A. D. Kopaneva

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of the Ministry of Healthcare of the Russian Federation

ORCID iD: 0009-0003-8093-3221

Moscow

Russian Federation

N. V. Myakova

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of the Ministry of Healthcare of the Russian Federation

ORCID iD: 0000-0002-4779-1896

Moscow

Russian Federation

D. V. Litvinov

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of the Ministry of Healthcare of the Russian Federation

ORCID iD: 0000-0002-7461-0050

Moscow

Russian Federation

A. I. Karachunskiy

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of the Ministry of Healthcare of the Russian Federation

Moscow

Russian Federation

G. A. Novichkova

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of the Ministry of Healthcare of the Russian Federation

ORCID iD: 0000-0002-2322-5734

Moscow

Russian Federation

References

  1. Foster, K.; Chapman, S.; Johnson, K. MRI of the marrow in the paediatric skeleton. Clin Radiol. 2004/07/21 ed. 2004, 59 (8): 651–673.
  2. Karampinos, D. C.; Ruschke, S.; Dieckmeyer, M.; Diefenbach, M.; Franz, D.; Gersing, A. S.; et al. Quantitative MRI and spectroscopy of bone marrow. J. Magn. Reson. Imaging 2018, 47 (2): 332–353.
  3. Chan, B. Y.; Gill, K. G.; Rebsamen, S. L.; Nguyen, J. C. MR Imaging of Pediatric Bone Marrow. Radiographics. 2016/10/12 ed. 2016, 36 (6): 1911–1930.
  4. Bainbridge, A.; Bray, T. J. P.; Sengupta, R.; Hall-Craggs, M. A. Practical Approaches to Bone Marrow Fat Fraction Quantification Across Magnetic Resonance Imaging Platforms. J. Magn. Reson. Imaging 2020, John Wiley and Sons Inc. 298–306.
  5. Abla, O.; Friedman, J.; Doyle, J. Performing bone marrow aspiration and biopsy in children: Recommended guidelines. Paediatr Child Health 2008, 13 (6): 499–501.
  6. Baum, T.; Rohrmeier, A.; Syväri, J.; Diefenbach, M. N.; Franz, D.; Dieckmeyer, M.; et al. Anatomical variation of age-related changes in vertebral bone marrow composition using chemical shift encoding-based water-fat magnetic resonance imaging. Front. Endocrinol. 2018, Frontiers Media S.A. 9 (APR).
  7. World Medical Association. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. JAMA 2013, 310 (20): 2191–2194.
  8. Whitehead, T. P.; Metayer, C.; Wiemels, J. L.; Singer, A. W.; Miller, M. D. Childhood leukemia and primary prevention. Curr. Probl. Pediatr. Adolesc. Health Care 2016, 46 (10): 317–352.
  9. Ruschke, S.; Pokorney, A.; Baum, T.; Eggers, H.; Miller, J. H.; Hu, H. C. H.; et al. Measurement of vertebral bone marrow proton density fat fraction in children using quantitative water-fat MRI. Magn. Reson. Mater. Phys. Biol. Med. 2017, 30 (5): 449–460.
  10. Samet, J. D.; Deng, J.; Schafernak, K.; Arva, N. C.; Lin, X.; Peevey, J.; et al. Quantitative magnetic resonance imaging for determining bone marrow fat fraction at 1.5 T and 3.0 T: a technique to noninvasively assess cellularity and potential malignancy of the bone marrow. Pediatr. Radiol. 2021, 51 (1): 94–102.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2023 Tereshchenko G.V., Kriventsova N.A., Kupriyanov D.A., Abu Jabal M.I., Kopaneva A.D., Myakova N.V., Litvinov D.V., Karachunskiy A.I., Novichkova G.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.